Brian W Roberts1, J Hope Kilgannon1, Benton R Hunter2, Michael A Puskarich3, Lisa Pierce4, Michael Donnino5, Marion Leary6, Jeffrey A Kline2, Alan E Jones3, Nathan I Shapiro5, Benjamin S Abella6, Stephen Trzeciak7,4. 1. Department of Emergency Medicine (B.W.R., J.H.K., S.T.). 2. Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis (B.R.H., J.A.K.). 3. Department of Emergency Medicine, University of Mississippi Medical Center, Jackson (M.A.P., A.E.J.). 4. Department of Medicine, Division of Critical Care Medicine (L.P., S.T.), Cooper University Hospital and Cooper Medical School of Rowan University, Camden, NJ. 5. Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D., N.I.S.). 6. Center for Resuscitation Science and Department of Emergency Medicine, University of Pennsylvania, Philadelphia (M.L., B.S.A.). 7. Department of Emergency Medicine (B.W.R., J.H.K., S.T.) trzeciak-stephen@cooperhealth.edu.
Abstract
BACKGROUND: Studies examining the association between hyperoxia exposure after resuscitation from cardiac arrest and clinical outcomes have reported conflicting results. Our objective was to test the hypothesis that early postresuscitation hyperoxia is associated with poor neurological outcome. METHODS: This was a multicenter prospective cohort study. We included adult patients with cardiac arrest who were mechanically ventilated and received targeted temperature management after return of spontaneous circulation. We excluded patients with cardiac arrest caused by trauma or sepsis. Per protocol, partial pressure of arterial oxygen (Pao2) was measured at 1 and 6 hours after return of spontaneous circulation. Hyperoxia was defined as a Pao2 >300 mm Hg during the initial 6 hours after return of spontaneous circulation. The primary outcome was poor neurological function at hospital discharge, defined as a modified Rankin Scale score >3. Multivariable generalized linear regression with a log link was used to test the association between Pao2 and poor neurological outcome. To assess whether there was an association between other supranormal Pao2 levels and poor neurological outcome, we used other Pao2 cut points to define hyperoxia (ie, 100, 150, 200, 250, 350, 400 mm Hg). RESULTS: Of the 280 patients included, 105 (38%) had exposure to hyperoxia. Poor neurological function at hospital discharge occurred in 70% of patients in the entire cohort and in 77% versus 65% among patients with versus without exposure to hyperoxia respectively (absolute risk difference, 12%; 95% confidence interval, 1-23). Hyperoxia was independently associated with poor neurological function (relative risk, 1.23; 95% confidence interval, 1.11-1.35). On multivariable analysis, a 1-hour-longer duration of hyperoxia exposure was associated with a 3% increase in risk of poor neurological outcome (relative risk, 1.03; 95% confidence interval, 1.02-1.05). We found that the association with poor neurological outcome began at ≥300 mm Hg. CONCLUSIONS: Early hyperoxia exposure after resuscitation from cardiac arrest was independently associated with poor neurological function at hospital discharge.
BACKGROUND: Studies examining the association between hyperoxia exposure after resuscitation from cardiac arrest and clinical outcomes have reported conflicting results. Our objective was to test the hypothesis that early postresuscitation hyperoxia is associated with poor neurological outcome. METHODS: This was a multicenter prospective cohort study. We included adult patients with cardiac arrest who were mechanically ventilated and received targeted temperature management after return of spontaneous circulation. We excluded patients with cardiac arrest caused by trauma or sepsis. Per protocol, partial pressure of arterial oxygen (Pao2) was measured at 1 and 6 hours after return of spontaneous circulation. Hyperoxia was defined as a Pao2 >300 mm Hg during the initial 6 hours after return of spontaneous circulation. The primary outcome was poor neurological function at hospital discharge, defined as a modified Rankin Scale score >3. Multivariable generalized linear regression with a log link was used to test the association between Pao2 and poor neurological outcome. To assess whether there was an association between other supranormal Pao2 levels and poor neurological outcome, we used other Pao2 cut points to define hyperoxia (ie, 100, 150, 200, 250, 350, 400 mm Hg). RESULTS: Of the 280 patients included, 105 (38%) had exposure to hyperoxia. Poor neurological function at hospital discharge occurred in 70% of patients in the entire cohort and in 77% versus 65% among patients with versus without exposure to hyperoxia respectively (absolute risk difference, 12%; 95% confidence interval, 1-23). Hyperoxia was independently associated with poor neurological function (relative risk, 1.23; 95% confidence interval, 1.11-1.35). On multivariable analysis, a 1-hour-longer duration of hyperoxia exposure was associated with a 3% increase in risk of poor neurological outcome (relative risk, 1.03; 95% confidence interval, 1.02-1.05). We found that the association with poor neurological outcome began at ≥300 mm Hg. CONCLUSIONS: Early hyperoxia exposure after resuscitation from cardiac arrest was independently associated with poor neurological function at hospital discharge.
Authors: Vinay M Nadkarni; Gregory Luke Larkin; Mary Ann Peberdy; Scott M Carey; William Kaye; Mary E Mancini; Graham Nichol; Tanya Lane-Truitt; Jerry Potts; Joseph P Ornato; Robert A Berg Journal: JAMA Date: 2006-01-04 Impact factor: 56.272
Authors: Stephen Trzeciak; R Phillip Dellinger; Joseph E Parrillo; Massimiliano Guglielmi; Jasmeet Bajaj; Nicole L Abate; Ryan C Arnold; Susan Colilla; Sergio Zanotti; Steven M Hollenberg Journal: Ann Emerg Med Date: 2006-11-07 Impact factor: 5.721
Authors: Byung Kook Lee; Kyung Woon Jeung; Hyoung Youn Lee; Seung Joon Lee; Yong Hun Jung; Wang Ki Lee; Tag Heo; Yong Il Min Journal: Am J Emerg Med Date: 2013-10-09 Impact factor: 2.469
Authors: Jukka Vaahersalo; Stepani Bendel; Matti Reinikainen; Jouni Kurola; Marjaana Tiainen; Rahul Raj; Ville Pettilä; Tero Varpula; Markus B Skrifvars Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Jerry P Nolan; Robert A Berg; Clifton W Callaway; Laurie J Morrison; Vinay Nadkarni; Gavin D Perkins; Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar; Kjetil Sunde; Alain Cariou Journal: Intensive Care Med Date: 2018-06-02 Impact factor: 17.440
Authors: Melika Hosseini; Robert H Wilson; Christian Crouzet; Arya Amirhekmat; Kevin S Wei; Yama Akbari Journal: Neurotherapeutics Date: 2020-04 Impact factor: 7.620
Authors: J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Shea; Brian M Fuller; Christopher Jones; Michael Donnino; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak; Brian W Roberts Journal: Resuscitation Date: 2018-11-16 Impact factor: 5.262
Authors: Sriram Ramgopal; Cameron Dezfulian; Robert W Hickey; Alicia K Au; Shekhar Venkataraman; Robert S B Clark; Christopher M Horvat Journal: Pediatr Crit Care Med Date: 2020-02 Impact factor: 3.624
Authors: Brian W Roberts; J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Shea; Michael Donnino; Christopher Jones; Brian M Fuller; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak Journal: Crit Care Med Date: 2019-01 Impact factor: 7.598